Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
A European Action Plan on Rare Diseases Is a Necessity, Not an Option – EPODIN
EPODIN/LinkedIn
Feb 24, 2026, 14:01

A European Action Plan on Rare Diseases Is a Necessity, Not an Option – EPODIN

European Patients Organization for Dysimmune and Inflammatory Neuropathies (EPODIN) shared a post on LinkedIn:

“A European Action Plan on Rare Diseases: a necessity, not an option

Between 27 and 36 million people in the European Union live with a rare disease.
95% of rare diseases lack of approved therapy.
Diagnostic delays often last years.

  • Access to care and therapies still depends heavily on where a patient lives.
  • In this context, the European Parliament is working on a European Action Plan on Rare Diseases.

 Why does the European level matter?

  • Because rare diseases are, by definition, scattered.
  • Because expertise is limited and unevenly distributed.
  • Because data remain fragmented.
  • Because purely national responses have clear limitations.

European added value is not theoretical. It already exists.

The European Reference Networks (ERNs) are a concrete example:

  • More than 1,600 centres of expertise connected across Europe
  • Virtual cross-border consultations for complex cases
  • Shared clinical expertise
  • Reduced duplication and improved access to specialised care

ERNs demonstrate that when Europe coordinates and structures expertise, patients benefit from more equitable and timely access to highly specialised care.

However, a future Action Plan will only succeed if patient organisations are placed at the heart of the system.
They are not just stakeholders. They are:

  • Identifiers of unmet needs
  • Holders of lived expertise
  • Partners in research and data generation
  • Advocates for equity and non-discrimination

A European rare disease framework is not only about technical coordination.
It is about responding to citizen-driven public health and equity challenges.

Any Action Plan must first and foremost:

  • Address transversal unmet needs
  • Reduce territorial and social inequalities
  • Strengthen structures that already demonstrate clear added value
  • Embed the patient voice structurally, not symbolically

Rare diseases are a medical challenge.
They are also a test for Europe’s commitment to health equity and social cohesion.
The response must be collective, coordinated and ambitious.”

Stay updated with Hemostasis Today.

EPODIN ERNs European patients organization for dysimmune and inflammatory neuropathies Headlines Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine Rare Diseases The European Reference Networks
NewsFeed